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Nramp1-functionality increases iNOS expression via
repression of IL-10 formation
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In mice, resistance to certain intracellular microbes depends on the expression of a late
phagosomal protein termed natural-resistance associated macrophage protein 1 (Nramp1,
Slc11a1). Nramp1-functionality is associated with alterations of cellular iron homeostasis
and a sustained pro-inﬂammatory immune response, including the formation of the
antimicrobial effector molecule NO. To investigate the underlying mechanism we used
RAW-264.7 murine macrophage cells stably transfected with a functional Nramp1 allele
(RAW-37) or Nramp1 non-functional controls (RAW-21). We found that the production of
and signalling by the anti-inﬂammatory cytokine IL-10 was signiﬁcantly enhanced in
macrophages lacking functional Nramp1. Upon infection of macrophages with Salmonella
typhimurium pathogen survival was signiﬁcantly better in RAW-21 than in RAW-37, which
inversely correlated to NO and TNF-a formation. Addition of a neutralising anti-IL-10
antibody to RAW-21 cells led to a signiﬁcantly reduced survival of S. typhimurium within
these cells and enhanced formation of NO and TNF-a reaching levels comparable to that
observed in cells bearing functional Nramp1. Oppositely, supplementation of iron to
RAW-21 cells further increased IL-10 formation.
Thus, Nramp1 mediates effective host defence in part via suppression of excessive IL-10
production which may relate to Nramp1-mediated reduction of cellular iron pools, thus
strengthening antimicrobial effector mechanisms.
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Introduction
Resistance to infection with intracellular pathogens such as
salmonellae, mycobacteria and leishmania is strongly inﬂuenced
by the expression of a gene termed Nramp1 (natural-resistance
associated macrophage protein 1, also called Slc11a1), which
encodes for a transport protein localised to the membrane of late
phagolysosomes [1]. The ability of murine Nramp1 to control
infection is abrogated by a single amino acid substitution, leading
to a fatal course of infection with intramacrophage microbes [2].
Loss of function causes defective intracellular targeting of mutant
Nramp1 [3]. In humans, NRAMP1 polymorphisms are associated
with increased susceptibility to infectious diseases such as
tuberculosis [4] or rheumatic diseases [5]. Murine Nramp1
transports divalent cations such as Fe
21,M n
21 and Zn
21;
however, the direction of transport is still under debate [5–7].
Some reports suggest iron to be transported into phagolysosomes
[6, 8], where it could enhance the formation of reactive oxygen
intermediates via the Haber–Weiss and Fenton reactions [9].
Other data propose an Nramp1-mediated iron efﬂux out of the
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the availability of the essential nutrient iron to intracellular
microorganisms [12, 13]. Modulation of intracellular iron trafﬁc
also exerts signiﬁcant effects on macrophage immune function,
since iron decreases the activity of IFN-g-mediated antimicrobial
pathways [14–16] including the formation of NO [17–19]. NO is
an antimicrobial effector molecule of macrophages produced
upon cytokine stimulation of the enzyme iNOS [20, 21]. Nramp1-
functionality increases NO formation [22, 23], which can be
traced back to transcriptional induction of iNOS involving
activation of transcription factors IRN regulatory factor (IRF-1)
and STAT-1 [24]. The importance of NO in host defense against
intramacrophage pathogens is reﬂected by the observation that
mice lacking iNOS are susceptible to leishmaniasis [25] and that
the addition of iNOS inhibitors impairs the ability of Nramp1-
resistant cells to clear infection with Mycobacterium tuberculosis
[26]. In addition, Nramp1-functionality results in upregulation of
various pro-inﬂammatory pathways [5].
Since the background for this phenomenon is far from being
understood, we herein investigated a putative effect of Nramp1-
functionality on the expression of SOCS and the anti-inﬂamma-
tory cytokine IL-10, which are well known as central negative
regulators of macrophage immune effector pathways [27, 28].
For this aim we employed murine RAW-264.7 macrophages
stably transfected with functional Nramp1 or controls and an
infection model using Salmonella typhimurium [29].
Results
Our previous observations have shown that Nramp1-mediated
upregulation of iNOS is related to STAT-1-mediated stimulation
of IRF-1 expression, leading to a prolonged activation of iNOS
transcription, while in macrophages lacking Nramp1 iNOS
expression signiﬁcantly declined 6h after cytokine stimulation
[24]. To ﬁnd out, whether this can be referred to modulation of
proteins that are known to be involved in the regulation of iNOS
mRNA formation or IFN-g signalling, we examined the expression
kinetics of genes of interest using quantitative real-time-PCR. We
found no signiﬁcant differences in the expression of IL-12, IL-18,
TGF-b, IFN-b, haeme oxygenose 1, SOCS-1 and SOCS-3 between
Nramp1-functional (RAW-37) and non-functional (RAW-21)
macrophages (data not shown). However, the expression
of the anti-inﬂammatory cytokine IL-10 was signiﬁcantly
different between the two cells after stimulation with IFN-g
plus LPS showing signiﬁcantly increased IL-10 levels in
Nramp1-deﬁcient cells (RAW-21) (Fig. 1). Similar results were
found when IL-10 protein levels in cell culture supernatants were
measured after infection of cells with S. tyhpimurium (Table 1).
To see whether the increased IL-10 formation results in
altered IL-10-mediated signalling via the JAK/STAT pathway
[27], we performed electro-mobility shift assays for the major
IL-10 inducible transcription factor STAT-3. STAT-3 DNA-binding
activity was detectable 3h after cytokine stimulation in RAW-21
cells and progressively increased over time. In contrast, in RAW-
37 cells STAT-3-binding activity was inducible by cytokine
stimulation but only to a lower level, especially after prolonged
cytokine treatment (Fig. 2). This observation compares well with
the increased formation of IL-10 found in cytokine-stimulated
RAW-21 cells.
To ﬁnd out, whether Nramp1-mediated differences in IL-10
production are functionally relevant, we infected macrophages
with S. typhimurium and examined bacterial growth after cyto-
kine stimulation in the presence or absence of a blocking anti-IL-
10 antibody. Initial uptake of S. typhimurium upon infection of
Figure 1. Effect of Nramp1 functionality on IL-10 mRNA expression.
RAW-21/37 cells were left untreated or stimulated with IFN-g (50U/mL)
and LPS (10ng/mL) for 3–12h and IL-10 mRNA expression was
quantiﬁed by real-time-PCR. Data are shown as means7SD of ﬁve
independent experiments performed in triplicate at the same time
point and expressed as relative IL-10 mRNA abundance after normal-
isation for 18S rRNA. po0.05; #, po0.01 when comparing RAW-21 with
RAW-37 under the same treatment conditions (two-sided Student’s
t-test).
Table 1. IL-10 protein expression after cytokine stimulation and/or infection with S. tyhpimurium
a)
Control IFN-g LPS S. typhimurium S. typhimurim1IFN-g
RAW-21 15.472.9 25.073.0 152.4723.2 113.8719.3 250.1736.7
RAW-37 11.673.6 16.473.0 ] 61.2711.1 ] 46.877.3 ] 85.2713.1 ]
a) RAW-21/37 cells were stimulated with IFN-g (50U/mL) or LPS (50ng/mL) or infected with S. typhimurium for 24h. IL-10
protein concentrations in cell culture supernatants were quantiﬁed by ELISA (pg/mL). Data are shown as means7SD
of six independent experiments. ], po0.01 when comparing RAW-21 with RAW-37 under the same treatment
conditions (two-sided Student’s t-test).
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growth was signiﬁcantly better controlled by Nramp1-expressing
cells (RAW-37) than in RAW-21 cells (data not shown). In both
cell lines, killing of salmonellae was enhanced by the addition of
IFN-g, but was still signiﬁcantly different between RAW-21 and
RAW-37 cells (Fig. 3). In RAW-37 cells, the addition of a blocking
anti-IL-10 antibody did not signiﬁcantly alter bacterial growth.
Strikingly, after neutralisation of IL-10 in RAW-21 cells, bacterial
replication was suppressed to levels comparable to those seen in
RAW-37 macrophages, both in presence and absence of IFN-g.
Since IL-10 is known to negatively effect macrophage effector
pathways, such as NO or TNF-a formation, and thus the immune
response towards Salmonella, we measured the levels of nitrite
(the stable end product of NO) in cell culture supernatants
(Fig. 4A). Nitrite levels were signiﬁcantly higher in RAW-37 cells
upon infection of macrophages with S. typhimurium and further
increased after stimulation of cells with exogenous IFN-g. After
addition of a blocking IL-10 antibody, NO production was
signiﬁcantly enhanced in RAW-21 cells, whereas in RAW-37
macrophages, nitrite levels were not affected by inhibition of
IL-10. To see, whether these results can be referred to altered
iNOS expression, we performed Western blots using protein
extracts obtained from infected macrophages (Fig. 4B). In
parallel to increased nitrite levels, RAW-37 expressed more iNOS
protein in response to Salmonella infection and with IFN-g
stimulation. Again, in RAW-21 cells the reduced iNOS protein
expression as compared with RAW-37 cells could be markedly
enhanced by neutralising antibodies directed against IL-10. This
indicated that the augmented production of IL-10 in infected
macrophages lacking functional Nramp1 leads to suppression of
iNOS protein expression and may thus impair killing of intra-
cellular S. typhimurium via reactive nitrogen intermediates. In
contrast, treatment of cells with an anti- isotype IgG1 antibody,
serving as an internal control, did not produce any signiﬁcant
changes described in Fig. 4A–C (details not shown), indicating
the observed effects of the anti-IL-10 antibody can be attributed
to blocking of IL-10.
In parallel to its impact on iNOS formation, anti-IL-10 treat-
ment signiﬁcantly changed TNF-a expression of S. typhimurium
infected RAW-21 cells (Fig. 4C). While TNF-a secretion was
signiﬁcantly higher in Nramp1-expressing RAW-37 cells following
infection with S. tryphimurium as compared with RAW-21, the
neutralisation of IL-10 by blocking antibodies signiﬁcantly
enhanced TNF-a production in RAW-21 cells, although levels
were still lower than those seen in RAW-37 macrophages.
To ﬁnd out, whether the inﬂuence of Nramp1 on IL-10
expression may be due to alterations in cellular iron homeostasis,
we examined the effect of cellular iron load on IL-10 production.
In accordance with IL-10 mRNA levels (Fig. 1), cytokine-stimu-
lated RAW-21 cells produced more IL-10 than RAW-37 cells as
determined by ELISA of cell culture supernatants. Interestingly,
the addition of FeCl3 to RAW-21 cells signiﬁcantly enhanced
IL-10 levels, whereas iron deprivation with the iron chelator
desferrioxamine reduced IL-10 formation. In contrast, in RAW-37
cells IL-10 levels in supernatants were low and not signiﬁcantly
changed by iron availability (Fig. 5).
Figure 2. STAT-3-binding afﬁnity in RAW-21/37 cells. Electro-mobility
shift assay showing binding activity of STAT-3 in nuclear extracts
derived from RAW-21/37 cells stimulated with IFN-g (50U/mL) and LPS
(10ng/mL) for 3–24h. The speciﬁcity of binding was conﬁrmed by cold
competition with a 30-fold excess of an unlabelled oligonucleotide
probe or an unlabelled probe containing a mutation within the STAT-3-
binding motif. Competition experiments were performed using nuclear
extracts from RAW-37 cells after cytokine stimulation for 12h. One out
of the three representative experiments is shown.
Figure 3. Modulation of S. typhimurium growth in RAW-21/37 cells by
anti-IL-10 antibody. RAW-21/37 cells were infected with S. typhimurium
(abbreviated as S.t.) and left untreated or stimulated with IFN-g (50U/
mL) and growth of S. typhimurium was quantiﬁed as described in the
Materials and methods. In addition, IL-10 was neutralised by addition of
a blocking IL-10 antibody (10mg/mL) either alone or prior to the
addition of IFN-g. A non-neutralising rat anti-mouse IgG antibody
(10mg/mL), used as isotype control, did not affect the intramacrophage
survival of S. typhimurium (data not shown). Data are expressed as
means7SD of ﬁve independent experiments. #, p o 0.01 when compar-
ing RAW-21 with RAW-37 cells under the same treatment conditions.
po0.01 when comparing RAW-21 cells treated with/without addition
of anti-IL-10 antibody (two-sided Student’s t-test).
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Nramp1-functionality is associated with a protection of mice
against infection with certain intracellular pathogens [5]. Part of
this host-protective effect has been referred to a more
pronounced stimulation of antimicrobial effector pathways of
macrophages including iNOS formation, oxidative stress or TNF-a
production [4, 5, 7, 22–24, 30].
One possible explanation for this would be a modulating
effect of Nramp1 on agonistic or antagonistic signals for these
pathogens. Herein, we provide evidence that Nramp1 inhibits
IL-10 expression as IL-10 mRNA and protein levels were signiﬁ-
cantly elevated in cells lacking functional Nramp1 following
cytokine stimulation.
These data are in perfect agreement with in vivo data indi-
cating an inverse association between Nramp1-functionality and
IL-10 formation [31–33].
However, most of these data originate from experiments with
Nramp1-susceptible or resistant mouse strains, thus implicating
possible inﬂuences of the respective genetic background on IL-10
production. Since our data were obtained with a macrophage cell
line stably transfected with either functional (RAW-37) or non-
functional Nramp1 (RAW-21), possible non-Nramp1-mediated inter-
strain differences and unknown genetic modiﬁers can be ruled out.
We further observed that the changes in IL-10 mRNA levels
resulted in corresponding alteration of DNA-binding afﬁnity of
STAT-3, the major player in IL-10 signalling [27, 34].
The kinetics of enhanced STAT-3-binding activity, reaching its
maximum after 12–24h, suggests that STAT-3 activation is rather
a consequence of IL-10 action and not a reason for IL-10 upre-
gulation.
Figure 5. Effect of iron perturbations on IL-10 formation. RAW-21/37
cells were left untreated or stimulated with IFN-g (50U/mL) and LPS
(10ng/mL), FeCl3 (100mM) or desferrioxamine (DFO, 100mM) for 12h
before IL-10 production was quantiﬁed by ELISA. Data are shown as
means7SD of three independent experiments. po0.01 when compar-
ing RAW-21 with RAW-37 under the same treatment conditions.
#, po0.01 when comparing with RAW-21 stimulated with IFN-g/LPS
alone (two-sided Student’s t-test).
Figure 4. Effect of anti-IL-10 on NO and TNF-a formation.
For all experiments RAW-21/37 cells were infected with S. typhimurium
and left untreated or stimulated with IFN-g (50U/mL) for 24h.
IL-10 was antagonised by a blocking IL-10 antibody (10mg/mL)
either alone or prior to treatment with IFN-g. (A) NO formation
was determined in culture supernatants using the Griess reagent.
(B) iNOS protein expression in RAW-21/37 cells as determined
by Western blotting. One of the three representative experiments
is shown. b-actin was used as a loading control. (C) TNF-a levels
in cell culture supernatants were determined by ELISA. (A, C)
Data are mean7SD of four independent experiments. po0.05; #,
po0,01 when comparing RAW-21 with RAW-37 cells under
the same treatment conditions. 1, po0.05 when comparing
RAW-21 cells treated with/without anti-IL-10 antibody (two-sided
Student’s t-test).
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cause repression of diverse host defence mechanisms; however, its
functional relevance in Nramp1-resistant or susceptible mice has not
been shown yet. Interestingly, S. typhimurium itself is capable of
inducing IL-10 production in infected macrophages [35], which is
part of their strategy to evade host immune mechanisms.
We herein demonstrated that macrophages lacking Nramp1
have an impaired killing of S. typhimurium which was associated
with a reduced activity of antimicrobial effector mechanisms of
macrophages, such as NO or TNF-a formation, the two latter
known to be inhibited by IL-10. Interestingly, abrogation of IL-10
by immune-depletion dramatically increased the ability of
RAW-21 cells to kill intracellular Salmonella growth and was
paralleled by enhanced NO formation and TNF-a production.
This provides clear evidence that part of the host-protective
function of Nramp1 is mediated via suppression of excessive IL-10
production and downstream signalling pathways.
This leads to the question as to how Nramp1-functionality
suppresses IL-10 expression, and at which level it operates. First,
Nramp1’s primary known function is divalent cation transport,
including iron [5–8]. Iron has been shown to inhibit IFN-g-mediated
pathways of macrophages. In contrast iron withdrawal, upon
administration of the iron chelator desferrioxamine, increased pro-
inﬂammatory immune pathways, such as NO or TNF-a formation,
and inhibition of anti-inﬂammatory pathways such as IL-10
formation, both in vitro and in vivo [14–16, 19, 36, 37]. Thus, by
reducing cytoplasmic iron pools, Nramp1 could exert such an effect
towards IL-10 formation. Interestingly, a recent study showed that
mice fed with a low iron diet had decreased serum levels of IL-10
[38]. Herein, we found that iron perturbations modulated IL-10
expression in RAW-21 but not in RAW-37 cells. Since we and others
have shown that Nramp1-bearing cells have signiﬁcantly lower
intracellular iron levels than RAW-21 cells [11, 39], altered iron
availability could be responsible for IL-10 downregulation in
Nramp1-expressing macrophages.
In addition, linked to the transport of divalent ions Nramp1
pumps protons leading to acidiﬁcation of the phagosome [7].
Proton accumulations and subsequent changes in pH could affect
the activity of transcription factors in the nucleus and cytoplasm
thus regulating the expression of immune genes. However, a
previous investigation found no difference in the expression of
the proton sensitive transcription factor NF-e ˆB between RAW-21
and 37 cells [24]. Finally, Nramp1 may alter pathogen response
to the host by altering the intraphagosomal micro-environment
and modulating the expression of microbial genes involved in
pathogen defense against the host [40, 41]. Moreover, Nramp1
could modulate the expression of upstream modulators regulat-
ing IL-10 expression, such as SOCS. However, at least by quan-
titative real-time-PCR we did not ﬁnd signiﬁcant differences in
SOCS-1 and 3 mRNA expression between RAW-21 and 37 cells,
although there was a trend towards higher SOCS-3 mRNA levels
in RAW-21 macrophages (details not shown).
Taken together, our results show that Nramp1 function leads
to suppression of anti-inﬂammatory pathways within macro-
phages by downregulation of IL-10 production. This underscores
the central regulatory role of IL-10 in the control of antimicrobial
pathways of macrophages and clearly shows that modulation of
IL-10 formation can lead to control of intracellular pathogens
such as S. typhimurium by IFN-g-mediated pathways. As Nramp1-
functionality also affects the intracellular iron trafﬁc and because
iron can affect IL-10 expression, these ﬁndings show a novel
aspect of how Nramp1 inﬂuences host effector mechanisms
against intracellular bacteria and thus further contribute to our
current understanding of the pleiotropic effects exerted by Nramp1.
Pharmacological or immunological manipulation of cellular iron
trafﬁc [42] and IL-10 activity [43, 44] may be promising additive
approaches for the treatment of intracellular infections at least
known to be controlled via Nramp1-functionality.
Materials and methods
Cell culture
Murine RAW-264.7 macrophages (originally isolated from
Nramp1-susceptible BALB/c mice) were stably transfected with
an expression vector containing Nramp1 (RAW-37) in the sense
or antisense direction (RAW-21) as described previously [45].
Nramp1 protein expression of RAW-37 cells was conﬁrmed by
Western blotting. Cells were grown in DMEM (Biochrom, Berlin,
Germany) containing 10% FCS, 2mM L-glutamine, 100U/mL
penicillin and 0.1mg/mL streptomycin, transfectants were
periodically selected for plasmid retention using G418 (Invitro-
gen, Lofer, Austria). Cells were stimulated with recombinant
murine IFN-g (R&D, Bad Nauheim, Germany) and LPS (Sigma-
Aldrich, Vienna, Austria). For infection experiments, 1 10
6
RAW-21/37 cells were seeded into 6-well plates in 2mL of DMEM
containing 10% FCS, 2mM L-glutamine and 50mg/mL ampicillin.
S. typhimurium strain C5RP4 (kindly provided by P. Mastroeni,
Cambridge University, Cambridge, UK), a virulent wild-type
isolate carrying natural resistance against ampicillin, was used
for all experiments and grown in Luria–Bertani (LB) broth
(Sigma-Aldrich) containing 50mg/mL ampicillin to late-logarith-
mic phase. After preincubation of S. typhimurium in complete
DMEM at 371C for 20min, RAW-21/37 cells were infected with
S. typhimurium at a MOI of 10 for 1h exactly as described [29].
Control cells were treated with complete DMEM without any
microbes. After 1h, RAW-21/37 cells were washed three times with
PBS (Invitrogen, Paisley, UK) and replaced with complete DMEM
containing 16mg/mL of gentamicin (Sandoz, Kundl, Austria) in
order to kill extracellular bacteria. Thereafter, macrophages were
treated with recombinant murine IFN-g (50U/mL; R&D), a
neutralizing monoclonal rat anti-mouse IL-10 IgG1 antibody
(10mg/mL; Biosource, Belgium) or an isotype control rat IgG1
antibody (10mg/mL; BD Bioscience, Schwechat, Austria). After an
incubation period of another 23h, RAW-21/37 cells were washed
three times in PBS and subjected to protein isolation. For
quantiﬁcation of intracellular Salmonellae, RAW-21/37 cells were
infected and stimulated exactly as detailed above, washed ﬁve times
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plated in appropriate dilutions onto LB agar plates containing
100mg/mL ampicillin.
Concentrations of murine TNF-a and IL-10 in cell culture
supernatants were determined by a commercially available ELISA
(both from BD Biosciences) according to the manufacturer’s
instructions and nitrite formation was determined by the Griess
reaction.
Quantitative real-time-PCR
Cells were harvested by scarping and washed with PBS, total RNA
was isolated by a standard guanidinium thiocyanate–phenol–
chloroform extraction and real-time-PCR analysis carried out
exactly as described [46]. Probes (50 FAM- and 30 TAMRA
labelled) and primer sequences were designed using Primer
Express software from Applied Biosystems and synthesised
by Microsynth (Balgach, Switzerland). The following primers
and probes were used for murine IL-10: Primer
forward: 50-CCAGAGCCACATGCTCCTAGA-30, Primer reverse:
50-TGGTCCTTTGTTTGAAAGAAAGTCT-30, TaqMan probe:
50-TGCGGACTGCCTTCAGCCAGG-30. Ampliﬁcation conditions
were 2min at 501C and 10min at 951C, followed by 40 cycles
for 15s at 951C and 1min at 601C. Data were normalised to 18S
ribosomal RNA.
Electro-mobility shift assays
Nuclear proteins were extracted as described by Schreiber et al.
[47]. For the generation of a radiolabelled probe the following
oligonucleotides, representing a standard consensus sequence
of STAT-3, were used: STAT-3 sense 50-GATCCTTCTGG-
GAATTCCTA-30, STAT-3 antisense 50-GATCTAGGAATTCCCA-
GAAG-30; for competition experiments, the following
oligonucleotides, containing a mutation within the
STAT-3-binding motif, were used: STAT-3-mutant sense
50-GATCCTTCTGGGCCGTCCTA-30, STAT-3-mutant antisense
50-GATCTAGGACGGCCCAGAAG-30; oligomers were annealed,
and overhanging ends were ﬁlled with [a-
32P]dCTP (Amersham,
Aylesbury, UK) and the three other non-radiolabelled dNTPs
(Pharmacia, Piscataway, NJ) using Klenow enzyme (Amersham)
as described [17]. For the preparation of unlabelled competitors,
dCTP instead of [a-
32P]dCTP was used. A total of 10mgo f
nuclear extracts were preincubated with 2mg of double-stranded
poly(dI-dC) poly(dI-dC) (Pharmacia) on ice for 10min before
addition of 2ng of the radiolabelled oligonucleotide probe
(50000cpm/ng). For competition studies, a 30-fold excess of
unlabelled oligonucleotide probe was added to the nuclear
extracts 10min before addition of the radioactive probe. The
DNA-binding reactions were performed in the presence of
200mM HEPES (pH 7.8), 10mM EDTA and 10mM DDT for
20min on ice. After addition of 87% glycerol as a loading
buffer, samples were separated on a 6% non-denaturing
polyacrylamide gel, which was subsequently dried and exposed
for autoradiography.
Western blotting
Proteins were extracted using cytoplasmic lysis buffer (25mM Tris-
H C lp H7 . 4 ,4 0 m MK C l ,1 %T r i t o nX - 1 0 0 )s u p p l e m e n t e dw i t h
aprotinin (1mg/mL) and leupeptin (1mg/mL) (all from Sigma,
Austria). Fifteen microgram of protein extracts were separated on
10% SDS-polyacrylamide gels and blotted onto nylon membranes
(Hybond-P, Amersham, Austria) as described [46]. After blocking
with 1 TBS buffer containing 2% dry milk and 0.1% Tween
(Merck, Austria), the membrane was incubated with a mouse anti-
iNOS-antibody (1:1000; BD Biosciences) or a rabbit anti-actin
antibody (1:800, Sigma), the latter used as a loading control. A
horseradish peroxidase-conjugated secondary goat anti-mouse IgG
antibody (1:4000; Dako, Austria) or goat anti-rabbit IgG antibody
(1:2000; Dako) was used to detect cross reactivity with SuperSignal
West Pico Chemiluminescent Substrate (Pierce, USA) and Hyperﬁlm
(Amersham-Pharmacia, Austria).
Statistics
Statistical analyses were carried out using SPSS software
(Version 13.0, SPSS, Chicago, USA). Calculations for signiﬁcant
differences between groups were carried out by two-sided
Student’s t-test.
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